Basilea Pharmaceutica AG, Allschwil Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, August 27, 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), a biopharmaceutical company focused on the needs…
On August 23, 2024, Gregory Weinhoff, the Chief Business Officer of Centessa Pharmaceuticals PLC (NASDAQ:CNTA), performed a significant transaction by selling 30,000 shares of the company’s stock. The sale was…
Mark Hahn, the Chief Financial Officer of Verona Pharma PLC (NASDAQ:VRNA), conducted a significant transaction on August 13, 2024, in which the insider sold 400,000 shares of the company’s stock.…
According to a recent SEC filing, Chief Scientific Officer Stephen Betz sold 3,000 shares of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) on August 12, 2024. Following this transaction, the insider now owns…
On August 12, 2024, Schaeffer Orlov S Nicole, Chief People Strategy Officer, sold 9,469 shares of Insmed Inc (NASDAQ:INSM) at a price of $72.49 per share. The transaction was documented…
